Univercells
Gosselies
About Univercells
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%. Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Total funding: $262.1M
- Funding stage: Late Stage Venture
- Last round: Series D (Oct 2022)
- Website: univercells.com
Industries & Categories
Biotechnology, Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/univercells-14730 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.